Herpes simplex viruses (HSVs) are prevalent human pathogens that establish latency in human neuronal cells and efficiently evade the immune system. It has been a major medical challenge to eradicate them and, despite intensive efforts, an effective vaccine is not available. We previously showed that upon infection of antigen-presenting cells, HSV type 1 (HSV-1) rapidly and efficiently downregulates the major histocompatibility complex class I-like antigen-presenting molecule, CD1d, and potently inhibits its recognition by CD1d-restricted natural killer T (NKT) cells. It suppresses CD1d expression primarily by inhibiting its recycling to the cell surface after endocytosis. We identify here the viral glycoprotein B (gB) as the predominant CD1d-interacting protein. gB initiates the interaction with CD1d in the endoplasmic reticulum and stably associates with it throughout CD1d trafficking. However, an additional HSV-1 component, the serine-threonine kinase US3, is required for optimal CD1d downregulation. US3 expression in infected cells leads to gB enrichment in the trans-Golgi network (TGN) and enhances the relocalization of both gB and CD1d to this compartment, suggesting that following internalization CD1d is translocated from the endocytic pathway to the TGN by its association with gB. Importantly, both US3 and gB are required for efficient inhibition of CD1d antigen presentation and NKT cell activation. In summary, our results suggest that HSV-1 uses gB and US3 to rapidly inhibit NKT cell function in the initial antiviral response.
During a viral infection the host uses both innate and adaptive arms of the immune system to prevent, suppress, or clear the pathogens, while many viruses encode proteins that allow them to evade the host response. Conventional CD8 ϩ and CD4 ϩ T cells are critical in antiviral immune responses, and viral evasion of antigen presentation by major histocompatibility complex (MHC) class I and II molecules have been studied extensively (reviewed in references 24 and 33) . Natural killer T (NKT) cells are an unusual subset of T cells that coexpress T-cell receptors (TCRs) and surface receptors typical of NK cells (5) . NKT cells influence diverse immune responses, including immunity to tumors and infectious diseases, as well as autoimmune diseases and allergies (5) . Most NKT cells express identical or similar TCRs, with predominant V␣24J␣18 in human and V␣14J␣18 in mouse, and are often called invariant NKT (iNKT) cells. Distinct from conventional CD4 ϩ and CD8 ϩ T cells, iNKT cells can be activated by both exogenous or endogenous lipid ligands. NKT cells are among the first peripheral responders during an immune response and are typically activated within hours, rapidly producing both Th1 and Th2 cytokines, and exerting critical immunomodulatory functions in the ensuing adaptive immune response (18) .
NKT cells are restricted by the nonpolymorphic MHC class I-like surface glycoprotein, CD1d, a member of CD1 gene family (3) . In humans, there are five CD1 gene members: CD1a, CD1b, CD1c, CD1d, and CD1e. Based on sequence homology, they are classified into two groups. Group I includes CD1a, CD1b, CD1c, and CD1e, while CD1d is the sole member of group II. There are no group I CD1 members in mice; however, there are two CD1d genes (CD1d1 and CD1d2) (5) . Structurally, CD1 is similar to MHC class I molecules in that it is a heterodimer formed by a 43-to 49-kDa heavy chain and ␤ 2 microglobulin (␤ 2 m). The heavy chain consists of three extracytoplasmic domains (␣1, ␣2, and ␣3), a transmembrane domain, and a short cytoplasmic tail. CD1d molecules present antigenic lipids or glycolipids to NKT cells. The extracytoplasmic ␣1 and ␣2 domains form a binding cleft similar to the peptide binding site of MHC class I molecules, except that it contains extremely hydrophobic pockets which can accommodate a variety of lipid antigens with hydrocarbon chains (17, 75) . As a transmembrane protein, CD1d is synthesized in the endoplasmic reticulum (ER) and traffics through trans-Golgi network (TGN) to the cell surface. Mediated by its cytoplasmic tail, cell surface CD1d can be endocytosed to endosomes and then recycle back to the cell surface. It is believed that mature CD1d molecules constantly recycle between cell surface and intracellular endosomal compartment, presumably to survey lipid antigens (reviewed in references 5 and 22) .
CD1d-restricted NKT cells play critical roles in immunity to different groups of viruses. Although the exact function of NKT cells in antiviral immunity remains unclear, it has been shown that innate-like NKT cells are rapidly activated after viral infection (14) . Patients with deficiencies in NKT cell development are hypersensitive to herpesvirus infection (59) . There is a selective loss of circulating NKT cells during HIV-1 infection (68) , and current treatments of HIV-1 patients by interleukin-2 (IL-2) or highly active antiretroviral therapy rapidly restore iNKT cell populations (49, 67) . In animal models, NKT-cell-deficient mice are much more susceptible to infection by herpes simplex virus type 1 (HSV-1) (21), influenza viruses (13) , respiratory syncytial virus (34) , and encephalomyocarditis virus (EMCV) (30) . On the other hand, the activation of NKT cells, mostly by the prototypical NKT cell ligand, ␣-galactosylceramide (␣-GalCer), greatly reduces the replication of mouse cytomegalovirus (69), hepatitis B virus (35) , influenza virus (29), respiratory syncytial virus (34), lymphocytic choriomeningitis virus (LCMV), and EMCV (71) . This critical role for NKT cells is also substantiated by the diverse mechanisms used by different groups of viruses to evade NKT cell function and the CD1d antigen presentation pathway (9, 62, 71, 73) .
A common tactic adopted by viruses to evade T cell function is to downregulate antigen-presenting molecules, including MHC class I and II glycoproteins, on the surface of antigenpresenting cells (24, 33) . To antagonize the potent antiviral function of NKT cells, many viruses, including HIV (8, 9, 23, 48) , HSV-1 (56, 73), Kaposi's sarcoma herpesvirus (KSHV) (62) , and LCMV (43) have evolved different mechanisms to inhibit CD1d expression and block the function of NKT cells. HIV Nef protein interacts with the cytoplasmic tail of CD1d, accelerates its endocytosis and relocalizes it to the TGN (63). In addition, HIV-1 also uses Vpu protein, to relocalize CD1d from the late endosome/lysosome to the early endosomal compartment (48) . KSHV uses the protein MIR-2 (for modulator of immune recognition 2) to ubiquitinate the cytoplasmic tail of human CD1d and enhance CD1d endocytosis, apparently without accelerating degradation (62) . LCMV also downregulates CD1d from the cell surface, but the mechanism is unknown (43) . Other viruses, including vaccinia and vesicular stomatitis viruses, inhibit NKT cell function not by inhibiting CD1d surface expression but rather by modulating the signal transduction pathways and the quality of CD1d lipid presentation (57, 58, 71) .
Herpesvirus infection is a major public health concern, causing both acute and life-long recurring infections that pose a constant threat to both immunocompetent and immunocompromised patients. Herpesviruses are categorized into three major groups, alpha-, beta-, and gammaherpesviruses. HSV is a member of the alphaherpesvirus family and can cause oral, ocular, and genital infections. Despite intensive studies our understanding of HSV pathogenesis is still limited. Currently, there are no vaccines available. Understanding the viral interaction with the immune system, particularly the innate immune system, may help to improve the vaccine efficiency and provide clues for novel antivirals. We have previously shown that HSV-1, upon infection, rapidly and substantially downregulates CD1d expression and inhibits NKT cell function. Unlike other viruses, HSV-1 does so primarily through suppressing CD1d recycling (73) . In this report we identify glycoprotein B (gB) and US3 as two viral factors functioning in suppressing CD1d antigen presentation.
MATERIALS AND METHODS
Viruses, cells, antibodies, and DNA constructs. Wild-type HSV-1 F strain was a gift from David Johnson (Oregon Health Science University, Portland, OR). gB-deficient virus and adenovirus expressing gB protein were generous gifts from Konstantin Kousoulas (Louisiana State University, New Orleans, LA). The gBdeficient virus was amplified and titered in gB-complementing Vero (D6) cells, also a gift from K. Kousoulas. US3-deficient (R7041) and vhs-deficient (R7621) viruses were gifts from Bernard Roizman (University of Chicago, Chicago, IL). The mouse monoclonal antibodies (MAbs) against human CD1d, CD1d51, and D5 were from Steven Porcelli (Albert Einstein College of Medicine, Bronx, NY) and Steven Balk (Harvard Medical School, Boston, MA), respectively. The anti-viperin MAb MaP.VIP was generated against the C-terminal domain of mouse viperin. Phycoerythrin (PE)-conjugated anti-CD1d monoclonal antibody (42.1) was purchased from BD Pharmingen. The anti-gB MAbs, H126 and 10B7, are from Virusys Co. Rabbit polyclonal anti-HSV1 antibody is from Dako Co. The rabbit polyclonal anti-gH/gL antibody was from Gary Cohen and Roselyn Eisenberg (University of Pennsylvania, Philadelphia, PA). Rabbit polyclonal anti-US3 antibody was from Bernard Roizman. MAbs, anti-mouse MHC class I, Y3, and anti-HLA DM, Map.DM1, have been described previously (36, 37) . MAbs against TGN46, Grp94, and LAMP1 were from Abcam, Stressgen, and BD Pharmingen, respectively. Alexa 488-, 568-, and 647-conjugated goat antimouse secondary antibodies were from Invitrogen/Molecular Probes. Alexa 647-conjugated anti-CD1d (CD1d51) antibody was generated by using purified CD1d51 antibody and a labeling kit from Invitrogen/Molecular Probes according to the manufacturer's instructions. The HSV-1 gB gene was subcloned by PCR from pSR175 construct (Gary Cohen and Roselyn Eisenberg, University of Pennsylvania, Philadelphia, PA) into pcDNA3.1.myc.hisA vector (Invitrogen). The HSV-1 strain 17 US3 gene was subcloned by PCR into pLPCX at a BglII/ NotI site from cosmid 48 (kindly provided by Andrew Davidson, MRC Virology, Glasgow, United Kingdom) (12) . US3 K220A (US3KA) mutant was generated by PCR mutating lysine 220 (codon AAG) to alanine (codon GCG) as reported by Wisner et al. (72) . The US3 gene from the HSV-1 KOS strain was cloned by PCR into pcDNA3.1 vector as reported previously (45) .
Pulse-chase labeling and immunoprecipitation. Radiolabeling of infected HeLa.CD1d cells and immunoprecipitation and reimmunoprecipitation were performed as described previously (73) . Briefly, HeLa.CD1d cells were infected with vhs-null HSV-1 virus for 6 h, starved in methionine-cysteine-free medium for 1 h, pulse-labeled using [ 35 S]methionine-cysteine for 15 min, and chased with nonradioactive methionine-cysteine-containing medium for the indicated times. Radiolabeled cells were lysed in 1% Brij98-containing Tris-buffered saline (TBS), immunoprecipitated with MAbs against CD1d, eluted, and reprecipitated using anti-gB antibodies as described above. Endoglycosidase H (Endo H; New England Biolabs) digestion of immunoprecipitated proteins was performed according to the manufacturer's instructions.
Coimmunoprecipitation. Coimmunoprecipitation with anti-CD1d monoclonal antibody of HSV-1-infected HeLa.CD1d cells were performed essentially as described previously (37) . Briefly, HeLa or HeLa.CD1d was infected by vhs-deficient virus at a multiplicity of infection (MOI) of 10 for 6 h, starved in methionine-cysteine-free medium for 1 h, and labeled using [
35 S]methionine-cysteine for 4 h before being lysed in TBS (pH 7.4) containing 1% Brij98 (Sigma). Postnuclear lysates were immunoprecipitated with the anti-CD1d MAb CD1d51. Precipitated protein was either directly loaded onto an SDS-PAGE gel or eluted in 1% SDS and reimmunoprecipitated by polyclonal anti-HSV-1 antibody, anti-gB MAb 10B7, or anti-gH/gL polyclonal antibody. To determine whether the coimmunoprecipitated protein was an N-linked glycoprotein, immunoprecipitated proteins were treated with peptide N-glycanase (PNGase; New England Biolabs) overnight before loading them onto SDS-PAGE gel. For direct cell surface coimmunoprecipitation of gB by anti-CD1d antibodies, HeLa.CD1d cells were infected by vhs-null HSV-1 for 6 h and pulse-labeled for 4 h before being incubated with anti-CD1d antibodies (CD1d51) or two isotype-matched control MAbs, eBioscience mIgG2b isotype control (eBMG2b) and anti-mouse MHC class I MAb (Y3), for 30 min on ice. After lysis and removal of the nuclei, CD1d-gB complexes were precipitated directly by using protein G-Sepharose beads. After several washes, the immunoprecipitated proteins were resolved by SDS-PAGE and autoradiography was performed.
Virus infection and flow cytometry. HeLa or HeLa.CD1d cells were infected by HSV-1 at an MOI of 10 for 6 or 12 h and then harvested in phosphatebuffered saline containing 1 mM EDTA. A half million cells were stained in 100 l with anti-CD1d, anti-HSV-1, or anti-gB antibodies and analyzed on a BD FACS Canto II flow cytometer as described previously (73) . Adenovirus-expressing gB was amplified in HEK293 cells and used to infect HeLa.CD1d cells at an MOI of 10.
Measurement of CD1d recycling by flow cytometry. HeLa.CD1d cells were either uninfected or infected by wild-type HSV-1 F strain or US3-deficient virus for 12 h or else cotransfected with pLPCX.US3 and peGFP-N1 for 40 h and treated with cycloheximide (10 g/ml) for 1 h before being used for recycling assays as described previously (73) . The cells were incubated with a purified anti-CD1d MAb, CD1d51, on ice for 30 min to block the surface CD1d before being incubated at 37°C for 20 min. Newly surface expressed, recycled, CD1d molecules, not associated with anti-CD1d antibodies, were then stained by a PEconjugated anti-CD1d MAb, 42.1, and fixed with 3.7% formaldehyde before being analyzed by flow cytometry. This approach separates the recycled CD1d from the CD1d molecules previously existing on cell surface. The percentage of recycled mean fluorescence intensity (MFI) was calculated as follows: [(postrecycling MFI Ϫ postblocking MFI)/(unblocked sample MFI Ϫ isotype control MFI)] ϫ 100%.
NKT cell stimulation assay. Human NKT cell stimulations using uninfected or infected HeLa.CD1d cells were performed as described previously (73) . Briefly, HeLa.CD1d cells were uninfected or infected with HSV-1 virus at an MOI of 10 for 12 h and then incubated with ␣-GalCer (a gift from Gurdyal S. Besra, University of Birmingham, Birmingham, United Kingdom) at a concentration of 100 ng/ml. Aliquots of 2 ϫ 10 4 loaded cells were incubated with 10 5 V␣24-positive DN2.D6 invariant NKT cells (a gift of Steven Porcelli, Albert Einstein College of Medicine, Bronx, NY) for 48 h. The culture supernatant was assayed by enzyme-linked immunosorbent assay for gamma interferon secretion using antibodies from BD Pharmingen.
Transient transfections, immunofluorescence, and Western blotting. These procedures were performed essentially as described previously (73, 74) . Transfection was performed using Lipofectamine 2000 (Invitrogen) or Bio-T reagent (Bioland). For immunofluorescence, HeLa.CD1d cells were seeded on a 10-mm coverslip (Fisher) and infected by HSV-1 for 6 h, fixed with 3.7% formaldehyde, and permeabilized with 0.1% saponin. The cells were then stained with anti-gB (H126), anti-CD1d (CD1d51), anti-Lamp1 (H4A3), or anti-TGN46 MAbs at concentrations of 5, 1, 2, and 2 g/ml, respectively. The cells were then stained with Hoechst 33258 (Invitrogen/Molecular Probes) at 2 g/ml. Alexa 488-, 568-, and 647-conjugated goat anti-mouse secondary antibodies were used at a concentration of 2 g/ml. Images were acquired and processed using a Nikon Eclipse C1 laser scanning microscope (Nikon Instruments, Inc., Melville, NY) fitted with a ϫ60 Nikon objective and Nikon Element image software. Immunoblotting for US3 expression was performed with rabbit polyclonal anti-US3 primary antibody, followed by horseradish peroxidase-conjugated secondary goat anti-rabbit antibody (Jackson Immunoresearch) and developed by ECL (Pierce) chemiluminescence.
RESULTS
HSV-1 gB stably interacts with CD1d in infected cells. As a first step to elucidate the molecular mechanism of HSV-1 downregulation of CD1d in infected cells, we performed coimmunoprecipitation experiments to identify proteins that interact with CD1d. HeLa or HeLa.CD1d cells were infected by vhs-null HSV-1 virus as previously reported (73) for 6 h, and cell lysates were immunoprecipitated using a specific MAb (CD1d51) against CD1d or a control MAb and subjected to SDS-PAGE analysis. As shown in Fig. 1A , anti-CD1d antibody specifically precipitates CD1d from uninfected and infected HeLa.CD1d cells but only coprecipitates a protein of ϳ120 kDa (p120) in the infected sample. Mature CD1d acquires heavily sialylated complex N-linked glycans at three of its four glycosylation sites (52) , resulting in a smeared appearance. Reimmunoprecipitation by anti-CD1d antibody has confirmed that the smear band is CD1d (data not shown). The coprecipitated p120 protein was absent from the control immunoprecipitations. To determine whether the p120 protein was a viral or cellular protein, we used a polyclonal anti-HSV-1 antibody, which was generated in rabbits to a lysate of rabbit corneal cells infected with HSV-1 and should recognize HSV-1-encoded proteins rather than cellular proteins. The proteins coprecipitated with CD1d were SDS-eluted and reimmunoprecipitated using the anti-HSV-1 antibody (Fig. 1B) . The p120 protein can be precipitated by the anti-HSV-1 antibody (lane 8), but not by normal rabbit serum (lane 5), suggesting it is an HSV-1 protein (6).
The HSV-1 genome encodes approximately 80 proteins and 12 glycoproteins (53). To determine whether p120 was a glycoprotein, we performed a PNGase digestion. A shift of ϳ15 kDa suggested that the p120 protein was a heavily N-linked glycosylated protein (Fig. 1C) . In the HSV-1 genome, there are two glycoproteins with molecular masses close to 120 kDa, glycoproteins B and H (gB and gH). We therefore used antibodies against gB or gH for reimmunoprecipitation. The anti-gB MAb reacted with the p120 protein (Fig. 1D) , while anti-gH/gL did not (data not shown). gB has six potential N-linked glycosylation sites (6), a finding consistent with the substantial shift after PNGase digestion (Fig. 1C) . Thus, the HSV-1 envelope glycoprotein gB was the predominant protein that interacts with CD1d.
To estimate the percentages of total CD1d and gB molecules present in the form of CD1d/gB complexes, we performed reciprocal immunoprecipitation and Western blot experiments. About 3 to 5% of CD1d and gB proteins can be detected as CD1d/gB complexes when either anti-CD1d (Fig. 1E , compare lanes 5 and 8) or anti-gB (Fig. 1F , compare lanes 6 and 9) antibodies were used for coimmunoprecipitation. The presence of two CD1d bands coprecipitated by anti-gB antibody suggest that both the two forms of CD1d, the immature unfolded CD1d heavy chain and folded, ␤ 2 m-associated CD1d (44) can be associated with gB. The percentage of CD1d associated with gB appears to be low. However, we reason that CD1d-gB interaction, similar to other protein-protein interactions, is a dynamic and transient process. On the other hand, both CD1d and gB proteins are membrane proteins, detergents have to be used to solubilize the proteins and even mild detergents, such as Brij98, used in our assays may disrupt the CD1d/gB complex. Therefore, the actual percentage of CD1d and gB in the complexes is likely to be higher, and this interaction may substantially affect CD1d expression and function.
At least some of the gB-CD1d interaction initiates in the ER, and the interaction is maintained during CD1d intracellular transport. To examine the kinetics of gB-CD1d interaction, we performed a pulse-chase analysis. HeLa.CD1d cells were infected with HSV-1 for 6 h and pulse-labeled for 15 min with [ 35 S]methionine-cysteine. At various time points cells were lysed and immunoprecipitations were performed with antiCD1d MAbs. Immunoprecipitated proteins were eluted in SDS and reimmunoprecipitated with an anti-gB MAb (10B7) or anti-CD1d antibody again to detect the associated gB protein and CD1d protein itself. Two anti-CD1d antibodies were used, D5 and CD1d51, which recognize unfolded CD1d heavy chain and folded, ␤ 2 m-associated CD1d heavy chain, respectively (36, 73) . Coimmunoprecipitation with both anti-CD1d antibodies can isolate the gB protein, which is consistent with coimmunoprecipitation results achieved with the anti-gB antibody (Fig. 1F) . Immunoprecipitation by D5 detected nascent CD1d heavy chain immediately after synthesis in the ER, as indicated by Endo H sensitivity, and most of these heavy chains remained in the ER ( Fig. 2A, upper panel) , which is consistent with previous reports that in both primary thymocytes and transfected cells, large amount of CD1d heavy chain reside in the ER (15, 44) . Reimmunoprecipitation with anti-gB antibody showed clearly that these CD1d heavy chains interacted with gB ( Fig. 2A, middle panel) , suggesting that CD1d can be associated with gB before forming a heterodimer with ␤ 2 m. At least some assembled CD1d/␤ 2 m heterodimers (immunoprecipitated by CD1d51 MAb, Fig. 2A , lower panel) were associated with gB before exiting the ER, as indicated by the Endo H sensitivity of gB protein at 0 and 15 min. However, at the later time points Endo H-resistant gB molecules were detected during chase up to 4 h, indicating that post-ER CD1d/␤ 2 m heterodimers also associate with gB after being transported to the cell surface and starting endocytosis/recycling cycles ( Fig.  2A , lower panel) (37, 73) . The constant increase in gB signal associated with CD1d ( Fig. 2A , lower panel) also suggested that more and more CD1d proteins are associated with gB after it traffics out of ER. To investigate whether CD1d molecules that express on the cell surface are associated with gB protein, we performed a cell surface direct immunoprecipitation, in which radiolabeled cells were incubated with antiCD1d MAb, CD1d51, before cell lysis. After washing off the excess antibodies, cells were then lysed and direct precipitation by protein G-beads. The detection of gB proteins specifically coprecipitated by anti-CD1d antibody but not by isotype control antibodies suggest that CD1d/gB complexes are present on the cell surface (Fig. 2B) . HSV-1 gB is required but not sufficient for CD1d downregulation. To determine whether the gB-CD1d interaction was responsible for CD1d downregulation, we infected HeLa.CD1d cells with either wild-type or gB-null HSV-1 viruses. While wild-type virus substantially downregulates CD1d expression by 6 h postinfection (Fig. 3A, left panel) , the gB-null virus does not downregulate CD1d (right panel). Although the gB-null virus is able to complete the replication cycle and release virions like wild-type viruses, its replication in noncomplementing cells is much weaker than wild-type viruses, reflected in the much smaller plaque size at 48 h postinfection (47) . This is probably due to the previously described interaction of gB with the ER stress sensor, protein kinase-like ER kinase (PERK) (50) . To examine whether the absence of gB affects viral gene expression at 6 h in gB-null virus-infected cells, we measured the total viral surface protein expression using the rabbit antibody against total HSV-1 proteins. As shown in Fig.  3B , the expression of total viral proteins is comparable, suggesting that the gB-CD1d interaction is required for CD1d downregulation at least in the early infection stage.
To determine whether gB-CD1d interaction is sufficient to downregulate CD1d, we expressed gB in HeLa.CD1d using a SDS-eluted followed by reimmunoprecipitation by normal rabbit serum (NRS) or rabbit polyclonal anti-HSV-1 antibodies. (C) The CD1d-coimmunoprecipitated protein (p120) is an N-linked glycoprotein. The CD1d-coimmunoprecipitated protein was either untreated or SDS-eluted and digested with PNGase. (D). CD1d-coimmunoprecipitated p120 is HSV-1 gB. The coimmunoprecipitated protein was either untreated or SDS eluted, followed by reimmunoprecipitation by using a control antibody (anti-mouse viperin MAb, Map.Vip) or anti-gB MAb, 10B7. (E and F) CD1d-gB interaction in infected cells. HeLa or HeLa.CD1d cells were infected with vhs-null HSV-1 virus and lysed before coimmunoprecipitation with an anti-CD1d MAb, CD1d51 (E), or an anti-gB MAb, H126 (F), and control antibodies (anti-mouse MHC I MAb Y3 or anti-HLA DM MAb Map.DM1, respectively). Immunoprecipitated proteins were blotted by anti-gB MAb 10B7 (E) or anti-CD1d MAb. D5 (F) antibodies, respectively. recombinant adenovirus expressing gB under the control of the cytomegalovirus promoter (Fig. 3C, left panel) . No CD1d downregulation was observed (right panel), suggesting that gB alone cannot reduce the cell surface expression of CD1d. HSV-1 US3 protein collaborates with gB to downregulate CD1d expression. The results shown in Fig. 3 suggest that an additional viral or host factor(s) collaborates with the gB protein to downregulate CD1d in infected cells. We therefore searched for viral or host proteins that interact or modulate gB protein trafficking. gB is the most conserved glycoprotein in the Herpesviridae family and plays a key role in mediating fusion between viral envelope and host cell membrane during viral entry (65) . Due to its fusogenic function, its cell surface expression must be tightly regulated (42) . Recently, the viral serine/threonine kinase US3 has been found to play a key role in modulating gB cell surface expression (31, 40, 72) , suggesting that it might collaborate with gB in affecting CD1d expression. HeLa.CD1d cells were transiently transfected with gB or US3 cDNA constructs or both, together with a peGFP-N1 plasmid to allow detection of transfected cells. CD1d expression in eGFP-positive cells was compared to that in green fluorescent protein (GFP)-negative cells (Fig. 4A) . Although the expression of gB alone failed to affect CD1d levels (Fig.  4B) , a finding consistent with the results using gB-expressing adenovirus, coexpression of gB and US3 efficiently downregulated CD1d from the cell surface (Fig. 4D) . Interestingly, US3 alone slightly reduced CD1d surface expression (Fig. 4C) . US3 is a viral serine/threonine protein kinase (31, 53, 72) . To examine whether the protein kinase activity is necessary for inhibiting CD1d expression, we generated a kinase-inactive US3 mutant by mutating conserved lysine 220 to alanine as reported previously (72) and cotransfected the mutant plasmid with the gB plasmid into HeLa.CD1d cells. CD1d downregulation was no longer observed (Fig. 4E) , suggesting that the kinase activity is required for the collaboration with gB that downregulates CD1d surface expression. Our initial experiments used the gB and US3 genes from different strains, KOS and strain 17, respectively. We also performed transient transfection using the two genes from the same strain (KOS), and CD1d downregulation was comparable to that in our initial experiment (results not shown), suggesting that in an actual HSV-1 infection, gB and US3 do collaborate with each other to downregulate CD1d.
We next examined whether US3 was required for efficient CD1d downregulation during an HSV-1 infection. HeLa.CD1d cells were infected by wild-type or US3-deficient virus and cell surface CD1d level was measured by flow cytometry. While the wild-type virus reduced CD1d expression by 70% at 12 h postinfection, the US3-deficient virus was much less effective, giving a reduction of only 38% (Fig. 5A) , suggesting that US3 plays an important role in the HSV-1-mediated inhibition of CD1d expression. Expression of US3 by wild-type but not mutant virus was verified by Western blotting (Fig. 5B) .
We previously showed that HSV-1 suppresses CD1d expression by inhibiting CD1d recycling (73) . To determine whether US3 exerts its effect at this stage, we used a flow cytometry- based recycling assay (73) to measure the CD1d recycling rate in cells with or without US3 expression. Cell surface CD1d molecules were first blocked by unconjugated anti-CD1d antibody, and the cells were then incubated at 37°C to allow internal CD1d molecules to recycle to cell surface, which were then stained with PE-conjugated anti-CD1d antibody. To examine whether US3 is sufficient to inhibit CD1d recycling, we expressed US3 in HeLa.CD1d cells. In this experiment, coexpressed GFP was used as surrogate marker for US3-transfected cells, and we compared the CD1d recycling rates in untransfected and transfected cells in the same sample to minimize the intersample variation. While the untransfected cells (ϪUS3) have a recycling rate of ca. 30% (Fig. 5C , left panel, and Fig. 5D ), the US3-transfected cells have a lower CD1d recycling rate of ca. 17% (Fig. 5C, right panel, and Fig. 5D ). To investigate whether US3 is necessary for inhibiting CD1d recycling during viral infection, we compared the CD1d recycling rates in uninfected cells, cells infected with wild-type F strain virus, or cells infected with US3-deficient viruses. In this experiment, the CD1d recycling rate in uninfected cells (ca. 30%) is consistent with that in untransfected HeLa.CD1d cells (Fig.   4D ). As previously reported (73) , the infection by wild-type F strain substantially inhibited (from ca. 30 to 10%, Fig. 5E ). However, the inhibition of CD1d recycling was substantially lower in cells infected with US3-deficient virus (from ca. 30 to 22%), suggesting that US3 is a critical factor in suppressing CD1d recycling during viral infection. US3 enhances colocalization of gB and CD1d in infected cells. To study how US3 and gB cooperate to downregulate CD1d, we examined the localization of gB and CD1d proteins in infected cells. HeLa.CD1d cells were infected by wild-type or US3-deficient viruses for 6 h and stained for CD1d, gB, the TGN marker (TGN46), or the late endosome/lysosome marker (LAMP1). In uninfected HeLa.CD1d cells, intracellular CD1d is mostly localized at LAMP1-positive late endosome/lysosome compartment as expected (37, 73) (Fig. 6B, upper panel) . In wild-type virus-infected cells, there is minimal colocalization of CD1d with LAMP1 (Fig. 6B, middle panel) . Instead, intracellular CD1d is enriched in the TGN, colocalized with gB (Fig.  6A, middle panel) . However, there is minimal enrichment of CD1d in the TGN or colocalization with gB in cells infected with US3-deficient viruses (Fig. 6A, lower panel) . In these infected cells, intracellular CD1d is not colocalized with LAMP1 either, suggesting its trafficking is also altered, although it is not redirected to trans-Golgi network ( Fig. 6A and B, lower panels).
Both US3 and gB are required for optimal inhibition of NKT cell function. To examine whether the downregulation of CD1d by HSV-1 gB and US3 proteins have functional implications, we performed NKT cell stimulation assays as previously described (73) . HeLa.CD1d cells were either left uninfected or were infected with wild-type, gB-deficient, or US3-deficient viruses, loaded with the prototypical NKT ligand, ␣-GalCer, and incubated with human NKT cell clones. NKT cell stimulation was assayed by measuring secretion of gamma interferon. As reported previously (73) , infection by wild-type HSV-1 substantially inhibited the ability of NKT cells to secrete gamma interferon by Ͼ80% (Fig. 7) . However, viruses lacking gB barely inhibited NKT cell function, while inhibition by the US3-deficient virus was less robust than for the wild type, reducing it by ca. 60% (Fig. 7) . The virtual absence of NKT cell inhibition by gB-null virus is consistent with the minimal downregulation of CD1d (Fig. 3A) . Infection by US3-deficient virus, however, still inhibited NKT cell function substantially. This is also consistent with the reduced but substantial downregulation of CD1d expression (Fig. 5A ) and moderate inhibition of CD1d recycling (Fig. 5E ) in cells infected by US3-deficient virus. Nevertheless, our results suggest that US3 is necessary for optimal downregulation of CD1d expression, and both gB and US3 play important roles in evading NKT cell function.
DISCUSSION
Using biochemical and genetic approaches, we have identified gB and US3 as two HSV-1 gene products that collaborate to downregulate CD1d in infected cells. Shortly after HSV-1 infection, at least some of CD1d molecules initiate gB interaction right after their synthesis in the ER. CD1d molecules also associate with gB protein throughout their trafficking in the cell. In the meantime, the recycling of CD1d and/or CD1d/gB complex is inhibited by the US3 protein kinase. Furthermore, US3 functions to retain CD1d/gB complex in the TGN, preventing CD1d expression on the cell surface.
gB is a protein with the longest cytoplasmic tail of all of the 12 glycoproteins in HSV-1 genome. In the early stages of infection, gB is enriched in the TGN (2, 46) . Robust endocytosis and retrieval of gB has been shown to be important for the virus to enrich glycoproteins intracellularly for virion assembly, regulating cell-to-cell spread and immune evasion (2, 16, 26, 27) . Two trafficking motifs, a tyrosine-based motif (YTQV) and a dileucine-based motif, have been identified (2) . Mutation of the tyrosine-based motif abolishes gB internaliza- FIG. 6 . US3 enhances gB and CD1d colocalization in HSV-1-infected cells. HeLa.CD1d cells were uninfected or infected with wildtype F strain or US3-null mutant viruses for 6 h and stained with MAbs against gB, TGN46, LAMP1, and CD1d. Nuclei were stained by using Hoechst stain. Images were acquired by using a Nikon Eclipse C1 laser scanning microscope fitted with a ϫ60 Nikon objective lens.
FIG. 7.
Both gB and US3 are required for optimal inhibition of CD1d-restricted NKT cell activation by HSV-1. HeLa.CD1d cells were left uninfected or were infected with wild-type F strain, gBnull mutant virus, or US3-null mutant virus for 12 h and used as antigen-presenting cells, which were loaded with vehicle or ␣-GalCer. The antigen-presenting cells were fixed and incubated with a human NKT cell clone, 6F5. Gamma interferon secretion was measured by enzyme-linked immunosorbent assay.
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HSV-1 gB AND US3 COLLABORATE TO DOWNREGULATE CD1d 8101 tion, whereas disruption of the dileucine motif impairs the trafficking of gB from early endosomes to the TGN (2). How this dileucine motif contributes to the retrieval of gB to the TGN is not clear. Our immunofluorescence results suggests that US3 protein kinase may play a critical role in this step, since gB fails to relocalize to the TGN in most of the cells infected by US3-deficient virus (Fig. 6 ). Some cell surface receptors, such as Memapsin 2, are phosphorylated at their di-leucine motif, and this phosphorylated motif acquires the ability to interact with Golgi-localized ␥-ear-containing ARFbinding (GGA) proteins, redirecting them from the recycling pathway to the TGN (25) . gB can be directly phosphorylated by US3 protein kinase and, in fact, multiple phosphorylation sites have been discovered near the dileucine motif (40, 72) . It will be interesting to determine whether US3 phosphorylation of gB at these sites leads to TGN retrieval. US3 can also inhibit CD1d recycling directly ( Fig. 5C and  D) , likely because of its kinase activity (Fig. 4E) . The targets of this phosphorylation and how they block CD1d recycling are unknown, and this is an area we are currently investigating. Phosphorylation of G-protein-coupled receptors (GPCRs), cell surface receptors by protein kinase A (PKA), and GRKs leads to retention of these receptors intracellularly (7, 55) . Tyrosine phosphorylation of CD1d has been reported and shown to be important for autocrine secretion of IL-10 in intestinal epithelial cells (10) . However, serine/threonine phosphorylation of CD1d has not been described. It has been proposed that US3 has an overlapping substrate specificity to cellular PKA (4). Using phosphorylation site prediction software for serine/threonine kinases, we identified the two putative noncanonical phosphorylation sites for PKA-like kinase (T 329 and S 330 ), in the sequence RFKRQT 329 S 330 , within the CD1d cytoplasmic tail. However, overexpression of US3 in CD1d-expressing cells did not result in CD1d phosphorylation (P. Rao and W. Yuan, unpublished results), suggesting US3 is unlikely to suppress recycling by direct phosphorylation of CD1d, but rather by phosphorylating an associated protein or a factor(s) in the CD1d recycling pathway.
Little is known about the CD1d recycling pathway, but recycling is required to present both endogenous and exogenous antigens to iNKT cells (37, 60) . At steady state, CD1d is localized in the late endosomal/lysosomal compartment (22, 37, 66) . The recycling routes of CD1d are not clear, namely, whether endocytosed CD1d is recycled through early/recycling endosomes (rab4-mediated short route) or endocytic recycling compartment (rab11-mediated long route) (19) . Regulation of either of these two recycling pathways by phosphorylation has been reported. For the short route, it has been found that in mitotic cells or insulin-stimulated cells, cdc2/cyclin B kinase phosphorylates rab4 and relocalizes it from early endosomal membranes to the cytosol and shuts off this vesicular recycling pathway (1) . For the long route, two phosphorylation-dependent regulatory events have been described. In Drosophila, it has been shown that myosin V, the major motor protein for the rab11-mediated recycling pathway in the cellular periphery, is phosphorylated by calcium/calmodulin-dependent protein kinase II (CaMKII), which efficiently shuts down endosomal recycling during mitosis (38) . In mammalian cells, the association of rab11-interacting protein, RIP11/FIP5, with rab11 is regulated by a phosphorylation/dephosphorylation cycle (54).
The Rip11/FIP5 protein mediates the interaction of rab11-associated recycling endosomes and microtubules for long-range transport of these endosomes (28) . Since CD1d is predominantly localized in late endosomal/lysosomal compartment, it is likely that at least a portion of CD1d recycles to cell surface through the rab11-mediated long route. Recently, the motor protein associated with Rip11/FIP5 has been identified as KIF3a (64), and we have found that purified US3 protein can phosphorylate KIF3a in vitro (Rao and Yuan, unpublished). We are currently investigating whether this phosphorylation efficiently shuts off CD1d recycling in vivo.
Our studies have demonstrated that HSV-1 uses two gene products, gB and US3, to efficiently downregulate CD1d from the cell surface. Nevertheless, as shown in Fig. 5A , infection using US3-deficient HSV-1 still leads to CD1d downregulation to a certain extent, suggesting the existence of additional viral factors downregulating CD1d expression. Due to the potent antiviral function of NKT cells, it is plausible that HSV-1 dedicates multiple genes to inhibit the expression of NKT cell-stimulating CD1d molecules. In fact, it has been shown that, for a single virus, multiple herpesvirus genes are dedicated to inhibiting MHC class I antigen presentation. For example, HCMV uses US2, US3, US6, and US11 to downregulate MHC class I expression (24) . We are currently identifying these putative additional HSV-1 factors downregulating CD1d expression.
NKT cells, as a group of potent immunoregulatory T cells, play critical roles in various immune responses (5). Our discovery that HSV-1 efficiently downregulates CD1d expression (73) and similar findings from another group (56) support an antiviral function of NKT cells in anti-HSV-1 immunity. However, the exact role of NKT cells in HSV-1 pathogenesis is not clear. In addition, whether the NKT cells play a critical role in anti-HSV-1 immunity has been under debate (11, 20, 21, 39) . It is possible that different results from different studies are due to differences in the virus and mouse strains used. Differences in viral virulence and host resistance can both contribute to the outcome of viral infection.
We have identified gB and US3 as two viral factors that together downregulate CD1d surface expression. However, gB is an essential gene for viral replication, so only US3-deficient virus can be used for in vivo pathogenesis studies. US3 is a critical in vivo virulence factor despite the fact that the growth of US3-deficient virus is comparable to that of wild-type virus in tissue culture cells (31, 41) . In vivo, US3-deficient HSV-1 and HSV-2 are almost avirulent when introduced by conventional routes, such as ocular or peritoneal inoculation (32, 41, 51, 61) . However, when US3-deficient HSV is inoculated directly into the brain, an immunoprivileged location, replication of US3-deficient virus is similar to that of wild-type virus (41) , suggesting that immune-mediated clearance at least partially contributes to the growth defect of US3-deficient virus in vivo. Recently, a mutant virus with an attenuated US3 (with the autophosphorylation site S217 mutated) showed a weakened US3 function and yet still causes infection in vivo (61) . It will be intriguing to compare the function of NKT cells in mice infected by this US3-attenuated virus versus wild-type virus. 8102 RAO ET AL. J. VIROL.
